The Bornewables™ ISCC PLUS-certified renewable polypropylene is helping Cytiva cut Scope 3 emissions while maintaining the high performance required for demanding healthcare applications.
Cytiva, a Danaher company and global leader in life sciences, is committed to reducing its Scope 3 emissions by exploring the use of renewable materials in place of the fossil-based resins traditionally used in its products. Biobased materials are still rare in this sector, and Cytiva is among the first to adopt them as alternatives to virgin fossil-based materials.
Borealis has been a long-term partner to Cytiva, providing advanced Bormed™ polyolefin solutions for a range of sensitive healthcare applications. This history of technical collaboration, combined with IMCD's comprehensive medical application knowledge and broad sustainability capabilities, created a strong foundation for introducing renewable resins into Cytiva’s product line without compromising the high levels of quality and performance its customers depend on.
"At Cytiva, we know that the material choices we make directly influence our Scope 3 emissions. Introducing renewable resins into our filtration devices shows that we can reduce our footprint without compromising the performance and reliability our customers depend on. It’s an important step in our journey toward more sustainable laboratory solutions."
Lacy Linney, Cytiva (Sustainability Product Transparency & Commercial Leader)
Cytiva began its move toward renewable materials with its widely used Whatman™ Puradisc and GD/X™ filtration devices—sterile and non-sterile syringe filters that provide fast and efficient filtration.
The challenge was significant: the filtration devices need to meet stringent performance standards, including the ability to withstand sterilization processes such as gamma irradiation. In addition, any renewable solution had to be a drop-in replacement, seamlessly fitting into existing production processes and fully compliant with the rigorous standards of the life sciences industry.
Cytiva selected a grade from Borealis’ Bormed™ portfolio, a specialized range of polyolefins developed specifically for healthcare applications. Backed by more than three decades of industry experience, Bormed provides the reliability of supply, regulatory support, and consistent quality that medical and life sciences applications demand.
The selected grade is the Bornewables™ version of Bormed™ HD810MO, which is produced using renewable feedstock derived entirely from waste and residue streams. The feedstock is ISCC PLUS–certified, ensuring full traceability from origin to resin, and Cytiva has achieved ISCC PLUS certification through to the final product—enabling verifiable sustainability claims.
The material also offers resistance to gamma sterilization and functions as a drop-in alternative to fossil-based resins—giving Cytiva confidence that it can maintain performance while reducing the environmental footprint of its products.
"We’re proud that Cytiva has selected a Bormed™ grade made with the Bornewables™ feedstock for its filtration devices. This project is a strong example of how we collaborate across the value chain to deliver materials that combine uncompromising performance with verifiable sustainability benefits."
Martin Fraissler, Borealis (Senior Application Marketing Manager Healthcare)
By switching to Bornewables, Cytiva has taken a measurable step toward lowering the Scope 3 emissions of its lab filtration portfolio. The ISCC PLUS certification ensures full traceability of renewable content, supporting transparency and credible reporting of emissions reductions. Because the resin behaves just like its fossil-based equivalent, there is no compromise on processability, functionality, sterilization resistance, or regulatory compliance.
The project highlights the value of collaboration across the supply chain: Cytiva, Borealis, and IMCD worked closely together to find an innovative solution that advances sustainability while keeping patient health as the top priority.
"As Borealis’ Offcial Bormed™ distribution partner in EMEA and Americas, IMCD brings specialized expertise in medical polymer grades to support Cytiva in adopting renewable solutions for critical healthcare applications. Our commitment to sustainability, combined with deep technical knowledge and local service ensures that healthcare innovators can access with confidence sustainable materials without compromising on quality or compliance."
Marc Gauthier, IMCD (Global Principal Manager, Medical Advanced Materials)
Don’t miss out! Join us at Hall 8 Stand M24, October 28-30, 2025, to experience our Bormed solutions up close. See you in Frankfurt and book a meeting here!
© Borealis
Borealis Healthcare: Because we care
As a leading supplier of advanced polyolefins for medical and diagnostic devices and pharmaceutical packaging, Borealis has been a reliable and trusted partner to the industry for over 25 years. The cornerstone of Borealis Healthcare is the Bormed™ Concept, founded on the principles of service, commitment and conformance, with unrivalled regulatory and technical support provided to material engineers to enable innovation. Medical polyolefins in the Bormed™ grade portfolio offer superior technical performance, fulfilling the most stringent requirements in terms of safety and quality. As a global supplier, Borealis can ensure long-term supply security. As a circular economy pioneer, Borealis offers material solutions from its ISCC Plus certified Bornewables™ and Borcycle™ C grade portfolios to deliver the same high material performance as virgin grades, but with a reduced carbon footprint. Enabling our customers to achieve their own sustainability targets is central to our EverMinds™ approach to promoting and accelerating plastics circularity.
Bormed™ is a trademark of Borealis AG.
www.borealisgroup.com | www.borealiseverminds.com
